
NSC 31150
CAS No. 51244-45-2
NSC 31150( —— )
Catalog No. M33810 CAS No. 51244-45-2
NSC 31150 is a potential PPAR agonist with antibacterial, antidiabetic and antioxidant activities and may be used to study cancer and bacterial infections.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 445 | Get Quote |
![]() ![]() |
5MG | 686 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
25MG | 1398 | Get Quote |
![]() ![]() |
50MG | 1822 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNSC 31150
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC 31150 is a potential PPAR agonist with antibacterial, antidiabetic and antioxidant activities and may be used to study cancer and bacterial infections.
-
DescriptionNSC 31150 is a potential PPAR agonist with antibacterial, antidiabetic and antioxidant activities and may be used to study cancer and bacterial infections.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetAntioxidant
-
RecptorAntioxidant | PPAR | Antibiotic
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51244-45-2
-
Formula Weight274.12
-
Molecular FormulaC10H5Cl2NO2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1SC(=CC2=CC=C(Cl)C=C2Cl)C(=O)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Crocetine dimethyl e...
Crocetine dimethyl ester (Dimethylcrocetin) is a saffronin derivative exhibiting antioxidant properties, inhibition of AChE activity, and suppression of cell growth and differentiation.
-
1,2,3,4,6-O-Pentagal...
1, 2, 3, 4, 6-Pentagalloylglucose and gallic acid from Pistacia lentiscus have antimutagenic and antioxidant activities.
-
Cyanidin Chloride
Cyanidin Chloride the main phenolic antioxidant in the grape (Vitis vinifera) in particular in the liposomal forms could be used for treatment of diabetes mellitus complications.